Low risk of inhibitor formation in haemophilia A patients following en masse switch in treatment to a third generation full length plasma and albumin-free recombinant factor VIII product (ADVATE®).
| Image |  |
|---|---|
| Description | scientific article published on 8 March 2011 |
| Author/s |
author: James S O'Donnell P.vincent Jenkins |
| Publication date | March 8, 2011 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |